Enlivex Therapeutics Ltd.
Utility Patents

Last updated:

List of all Enlivex Therapeutics Ltd. patents 5 in total

Status Patent
Grant
Utility: Combination immune therapy and cytokine control therapy for cancer treatment External link
Filling date: 7 Sep 2025 Issue date: 3 May 2022
Grant
Utility: Combination immune therapy and cytokine control therapy for cancer treatment External link
Filling date: 7 Sep 2025 Issue date: 19 Apr 2022
Grant
Utility: Combination immune therapy and cytokine control therapy for cancer treatment External link
Filling date: 7 Sep 2025 Issue date: 11 May 2021
Grant
Utility: Therapeutic apoptotic cell preparations, method for producing same and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Therapeutic pooled blood apoptotic cell preparations and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 8 Dec 2020

Showing 1 to 5 of 5 patents.